Julien Leclaire

Julien Leclaire

Auto-generated profile, based on publicly available information

Julien Leclaire

UCBL, CNRS ICBMS UMR 5246, 43 bvd du 11 Novembre 1918, Villeurbanne, France

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2006 in Chemical Reviews
Verified
Journal Article
Closed access
PCPeter T. Corbett
Peter T. Corbett
JLJulien Leclaire
Julien Leclaire
LVLaurent Vial
Laurent Vial
KWKevin R. West
Kevin R. West
JWJean-Luc Wietor
Jean-Luc Wietor
SOSijbren Otto
Sijbren Otto

1 June 2004 in Journal of General Virology
Verified
Journal Article
Closed access
Jerome SolassolJerome Solassol
Jerome Solassol
CCCarole Crozet
Carole Crozet
VPVeronique Perrier
Veronique Perrier
JLJulien Leclaire
Julien Leclaire
FBFlorence Béranger
Florence Béranger
SLSylvain Lehmann
Sylvain Lehmann
Over the last 30 years, many drugs have been tested both in cell culture and in vivo for their ability to prevent the generation of prions and the development of transmissible spongiform encephalopathies. Among the compounds tested, dendrimers are defined by their branched and repeating molecular structure. The anti-prion activity of new cationic phosphorus-containing dendrimers (P-dendrimers) with tertiary amine end-groups was tested. These molecules had a strong anti-prion activity, decreasing both PrPSc and infectivity in scrapie-infected cells at non-cytotoxic doses. They can bind PrP and decrease the amount of pre-existing PrPSc from several prion strains, including the BSE strain. More importantly, when tested in a murine scrapie model, the dendrimers were able to decrease PrPSc accumulation in the spleen by more than 80 %. These molecules have a high bio-availability and therefore exhibit relevant potential for prion therapeutics for at least post-exposure prophylaxis.

13 July 2006 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
LVLaurent Vial
Laurent Vial
RLR. Frederick Ludlow
R. Frederick Ludlow
JLJulien Leclaire
Julien Leclaire
RPRuth Pérez-Fernández
Ruth Pérez-Fernández
SOSijbren Otto
Sijbren Otto

12 September 2018 in Green Chemistry
Verified
Journal Article
Closed access
PDF file
JLJulien Leclaire
Julien Leclaire
DHDavid J. Heldebrant
David J. Heldebrant
Chemists, engineers, scientists, lend us your ears… Carbon capture, utilisation, and storage (CCUS) is among the largest challenges on the horizon and we need your help.

1 August 2003 in Oligonucleotides
Verified
Journal Article
Closed access
MMMaria Maszewska
Maria Maszewska
JLJulien Leclaire
Julien Leclaire
MCMarcin Cieslak
Marcin Cieslak
BNBarbara Nawrot
Barbara Nawrot
AOAndrzej Okruszek
Andrzej Okruszek
JMJean-Pierre Majoral
Jean-Pierre Majoral
A series of water-soluble polycationic dendrimers with a phosphoramidothioate backbone (P-dendrimers) was studied in human cell culture. Preliminary studies have shown that P-dendrimers of series 1 and 2, possessing N,N-diethyl-ethylenediamine hydrochloride functions at the surface, show rather moderate cytotoxicity toward HeLa, HEK 293, and HUVEC cells in a standard MTT assay in serum-containing medium, generally lower than lipofectin. The experiments of cellular uptake have shown the necessity for the presence of serum for transfection with P-dendrimers of series 1 and 2. These compounds efficiently delivered fluorescein-labeled oligodeoxyribonucleotide into HeLa cells in serum-containing medium, but they failed to do so in HUVEC cell culture. The dendrimers were found to be successful mediators of transfection of the HeLa cells with a DNA plasmid containing the functional gene of enhanced green fluorescent protein (EGFP).

6 February 2004 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
JLJulien Leclaire
Julien Leclaire
YCYannick COPPEL
Yannick COPPEL
Anne-Marie CaminadeAnne-Marie Caminade
Anne-Marie Caminade
JMJean-Pierre Majoral
Jean-Pierre Majoral